SANGAMO BIOSCIENCES (NASDAQ:SGMO)
4.81
0.04 (0.82%)
| SANGAMO BIOSCIENCES (NASDAQ:SGMO) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $4.85 | 52 Week High | $9.39 | ||
| Open | $4.84 | 52 Week Low | $2.68 | ||
| Day High | $4.92 | P/E | N/A | ||
| Day Low | $4.80 | EPS | $-0.47 | ||
| Volume | 13,168 | ||||
| More SGMO Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| VG | 3 | PSEM | 2 |
| ASCA | 2 | FOR | 2 |
| GHDX | 2 | BRS | 2 |
| CMCSA | 2 | OIIM | 2 |
| DDSS | 2 | THQI | 2 |
| ALVR | 2 | DCP | 2 |
Entities who have mentioned SGMO
- Merriman Curhan Ford | View Related Stories »
- Brean Murray Carret & Co. | View Related Stories »
- Citi | View Related Stories »
- JPMorgan | View Related Stories »
- Piper Jaffray | View Related Stories »
- Scopia Capital | View Related Stories »
- 13G | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Cantor Fitzgerald | View Related Stories »
- Notable Calls | View Related Stories »
- Crude Oil | View Related Stories »
- Trading Radar | View Related Stories »
- Layoffs | View Related Stories »
- Vanguard | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
- Lazard | View Related Stories »
- Oil Inventories | View Related Stories »
- Wachovia | View Related Stories »
- Dividend | View Related Stories »
- Mark Cuban | View Related Stories »
- Susquehanna International Group of Companies | View Related Stories »
- UBS | View Related Stories »
- ADP Employment Report | View Related Stories »
- Federal Open Market Committee | View Related Stories »
View All Major News StreetInsider.com Major News for SGMO
- Sangamo BioSciences (SGMO) Tops Q4 EPS by 2c
- Sangamo (SGMO) Reports Q3 Loss of $0.12, Beats by 1c
- Sangamo (SGMO) Reports Q2 Loss of $0.11, Beats by 4c
View All ReportsStreetInsider.com Reports on SGMO
- Sangamo BioSciences (SGMO) Tops Q4 EPS by 2c
- Trading Radar for 02/03: Cisco (CSCO), ON Semi (ONNN), Visa (V), Novellus (NVLS), Monster Worldwide (MWW) Report
- Sangamo BioSciences (SGMO) Announces Preliminary SB-728-T Phase I Data
- Sangamo BioSciences (SGMO) Initiates Two ZFP Clinical Trials
- Sangamo BioSciences (SGMO) Presents Preliminary Data from ALS Treatment ZFP Therapeutic Phase 2
View All Press ReleasesCompany Press Releases on SGMO
- Sangamo BioSciences Reports Fourth Quarter and Full Year 2009 Financial Results
- Sangamo BioSciences Announces Presentation at BIO CEO & Investor Conference
- Sangamo BioSciences Announces Fourth Quarter and Full Year 2009 Conference Call and Webcast
- Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 1 Safety Trial of SB-728-T for HIV/AIDS
- Sangamo BioSciences Advances ZFP Therapeutic(TM) Pipeline
StreetInsider Reports on SGMO by Category
View All BlogsBlogs on SGMO
- 19 'Babies with Bathwater' and 1 'Dog with Fleas' Stocks for the Week
- Biotech Companies Turn to Capital Markets
- 2 'Babies with Bathwater' and 20 'Dogs with Fleas' Stocks for the Week
- Sangamo (SGMO): Progress in adult stem calls?
- Top Pre-Market Analyst Upgrades (AEZS, AKAM, CNQR, HK, SJT, SGMO, THRX)
View All FilingsSEC Filings on SGMO
- Form 8-K SANGAMO BIOSCIENCES INC For: Feb 03
- Form SC 13G SANGAMO BIOSCIENCES INC Filed by: BlackRock Inc.
- Form 4 SANGAMO BIOSCIENCES INC For: Dec 31 Filed by: Wolff Henry Ward
Comments on recent SGMO articles
Comments on SGMO
No comments are currently available.
on Jul 2, 2009
at 06:21 PM sucessful ZFN knockpout of 2 CHO genes So are we to assume that Genentech is targeting OVARIAN CANCER? They succesfully knocked out those genes to stop the cancer?
Article: Sangamo BioSciences (SGMO) Announced Key Milestone Reached in Cell Engineering Agreement With Genentech